½ÃÀ庸°í¼­
»óǰÄÚµå
1596573

¿¬Á¶Á÷ ¼öº¹ ½ÃÀå : Á¦Ç°º°, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Soft Tissue Repair Market by Product (Fixation Product, Laparoscopic Instruments, Mesh Patch), Application (Dental & Breast Reconstruction Repair, Hernia Repair, Orthopedic) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿¬Á¶Á÷ ¼öº¹ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 120¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 133¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 11.32%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 254¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

¿¬Á¶Á÷ º¹±¸ ½ÃÀå¿¡´Â ±ÙÀ°, Àδë, ÈûÁÙ, ÇǺΠµî ½Åü ³» ¼Õ»óµÈ ¿¬Á¶Á÷À» ȸº¹, ´ëü, º¹±¸Çϱâ À§ÇÑ ÀÇ·á ½Ã¼ú, Á¦Ç° ¹× ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ½ºÆ÷Ã÷, »ç°í, ³ëÈ­·Î ÀÎÇÑ ¼Õ»ó°ú Á¶Á÷ ÁöÁö ¹× Àç°ÇÀ» ÇÊ¿ä·Î ÇÏ´Â ¿Ü°úÀû °³ÀÔ¿¡ ´ëÀÀÇØ¾ß ÇÒ Çʿ伺ÀÔ´Ï´Ù. Å»Àå º¹¿ø, À¯¹æ Àç°Ç, ÇǺΠÀç°Ç µîÀÇ ¿ëµµ·Î »ç¿ëµÇ¸ç, ÃÖÁ¾ »ç¿ëÀÚ´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ȯÀÚ ¼ö¼ú¼¾ÅÍ µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î´Â ¿¬Á¶Á÷ ¼Õ»óÀÇ À¯º´·ü Áõ°¡, »ý¹°ÇÐÀû Á¦Á¦ ¹× ºñ°è ±â¼úÀÇ ¹ßÀü, ¼Õ»óµÇ±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼ú ±â¼ú ¹× Àç»ýÀÇ·á ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ±×·¯³ª °í±Þ ¼öº¹ Á¦Ç°ÀÇ ³ôÀº °¡°Ý, ½Å±â¼ú¿¡ ´ëÇÑ ±ÔÁ¦ Àå¾Ö¹°, Á¦ÇÑµÈ º¸Çè »óȯ ¿É¼Ç µîÀÌ ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ƯÈ÷ °¡°Ý ¹× Á¢±Ù¼º¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ºü¸¥ Ä¡À¯¿Í ÇÕº´ÁõÀÌ Àû°í ºñ¿ë È¿À²¼ºÀÌ ³ôÀº ÷´Ü »ý¹°ÇÐÀû Á¦Á¦ÀÇ °³¹ß°ú ȯÀÚ ¸ð´ÏÅ͸µ ¹× ¼ö¼ú ÈÄ °ü¸®¿¡¼­ µðÁöÅÐ Çコ ±â¼úÀÇ È°¿ë¿¡ ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ȯ°æ ģȭÀûÀÌ°í »ýü ÀûÇÕ¼ºÀÌ ³ôÀº ¼ÒÀç¿Í °³ÀÎ ¸ÂÃãÇü Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¿¬±¸¿¡ ÅõÀÚÇÔÀ¸·Î½á Çõ½ÅÀ» ÀÌ·ê ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ Ä¡¿­Çϸç, ºü¸¥ ±â¼ú Çõ½Å°ú Æ´»õ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ½Å»ý ±â¾÷ÀÇ ÁøÀÔÀ¸·Î Ư¡Áö¾îÁý´Ï´Ù. ±â¾÷µéÀº ÀÌ·¯ÇÑ ±Þ°ÝÇÑ º¯È­¿¡ ÀûÀÀÇϰí, ±ÔÁ¦ ¾÷µ¥ÀÌÆ®¿¡ ´ëÀÀÇϰí, Æ÷Æ®Æú¸®¿ÀÀÇ ´Ù¾ç¼ºÀ» ³ôÀ̱â À§ÇØ Á¦ÈÞ ¹× Àμö¿¡ ³ª¼­¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, ÇコÄɾî ÀÎÇÁ¶ó°¡ ¼ºÀåÇÏ°í ¹ÌÃæÁ· ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡ ÁýÁßÇϰí, ƯÁ¤ Àα¸ Áý´Ü°ú Áö¿ªÀÇ ´ÏÁî¿¡ ¸Â´Â Á¦Ç°À» Á¦°øÇÔÀ¸·Î½á »õ·Î¿î ½ÃÀå ºÎ¹®À» È¿À²ÀûÀ¸·Î È®º¸Çؾ߸¸ ¼ºÀå¼¼¸¦ ±Ø´ëÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 120¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 133¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 254¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 11.32%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿¬Á¶Á÷ º¹±¸ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿¬Á¶Á÷ ¼öº¹ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ëÈ­¿Í ºñ¸¸À¸·Î ÀÎÇÑ ¿¬ºÎÁ¶Á÷ ¼Õ»ó ¹ß»ý·ü »ó½Â
    • Á¤Çü¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
    • Á¤ºÎ ¹× ¹Î°£´ÜüÀÇ ÀÚ±Ý Áö¿ø Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ¼ö¼ú ºñ¿ë
  • ½ÃÀå ±âȸ
    • Á¶Á÷ Àç»ý¿¡ ÀÖ¾î ±â¼úÀûÀ¸·Î Áøº¸µÈ Á¦Ç° °³¹ß
    • Á¶Á÷ Àç»ý¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¶»ç
  • ½ÃÀå °úÁ¦
    • ÀÎ½Ä ºÎÁ· ¹× Á¦ÇÑÀû »óȯ Á¤Ã¥

Portre's Five Forces: ¿¬Á¶Á÷ º¹¿ø ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿¬ºÎÁ¶Á÷ º¹¿ø ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿¬ºÎÁ¶Á÷ º¹±¸ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¿¬ºÎÁ¶Á÷ º¹±¸ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¿¬Á¶Á÷ º¹±¸ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¿¬Á¶Á÷ ¼öº¹¹° ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿¬Á¶Á÷ ¼öº¹¹° ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¿¬ºÎÁ¶Á÷ º¹±¸ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¿¬Á¶Á÷ º¹±¸ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå : Á¦Ç°º°

  • °íÁ¤ Á¦Ç°
    • °£¼· ³ª»ç
    • ºÀÇÕ ¾ÞÄ¿
  • º¹°­°æ ±â±¸
  • ¸Þ½Ã ÆÐÄ¡
    • »ý¹°ÇÐÀû ¸Þ½Ã
      • µ¿Á¾ À̽Ä
      • ÀÌÁ¾ À̽Ä
    • ÇÕ¼º ¸Þ½Ã

Á¦7Àå ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå : ¿ëµµº°

  • Ä¡°ú ¹× À¯¹æ Àç°Ç ¼öº¹
  • Ç츣´Ï¾Æ ¼öº¹
  • Á¤Çü¿Ü°ú
    • °æ¸· ¼öº¹ ¹× ·»µ· °­È­
    • ½ºÆ÷Ã÷ ÀǾàǰ
  • ÇǺΠ¼öº¹
  • Áú ½½¸µ ¼öº¹

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Acera Surgical Inc.
  • Allergan, PLC
  • Arthrex, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cerner Corporation
  • CONMED Corporation
  • CryoLife, Inc.
  • GE Healthcare Inc.
  • Institut Straumann AG
  • Integra Lifesciences Corporation
  • Johnson & Johnson
  • Lifenet Health, Inc.
  • Medline Industries, Inc.
  • Medtronic PLC
  • Organogenesis Holdings Inc.
  • Pfizer Inc
  • Smith & Nephew PLC
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc
LSH

The Soft Tissue Repair Market was valued at USD 12.01 billion in 2023, expected to reach USD 13.36 billion in 2024, and is projected to grow at a CAGR of 11.32%, to USD 25.46 billion by 2030.

The soft tissue repair market encompasses medical procedures, products, and technologies designed to restore, replace, or repair damaged soft tissues in the body, such as muscles, ligaments, tendons, and skin. This market is driven by the necessity to address injuries from sports, accidents, and aging, as well as surgical interventions that require tissue support or reconstruction. Applications include hernia repair, breast reconstruction, and skin repair, with end-users such as hospitals, clinics, and ambulatory surgical centers. Factors propelling market growth include the increasing prevalence of soft tissue injuries, advancements in biologics and scaffold technology, and a rising elderly population more susceptible to injuries. The market benefits from ongoing innovations in minimally invasive surgery techniques and improvements in regenerative medicine. However, growth is challenged by high costs of advanced repair products, regulatory hurdles for new technologies, and limited reimbursable insurance options, particularly affecting affordability and accessibility. Emerging opportunities lie in developing cost-effective, cutting-edge biologics that offer faster healing and fewer complications, as well as leveraging digital health technologies in patient monitoring and postoperative care. Businesses can innovate by investing in research for eco-friendly, biocompatible materials, and customization options for personalized treatment. The market is dynamic and competitive, characterized by rapid technological innovation and the entrance of startups offering niche solutions. Companies must adapt to these fast-paced changes, ensuring compliance with regulatory updates and engaging in partnerships or acquisitions to enhance portfolio diversity. To maximize their footprint, firms should focus on emerging markets with growing healthcare infrastructure and unmet needs, aligning product offerings with specific demographic or regional needs to capture new market segments effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 12.01 billion
Estimated Year [2024] USD 13.36 billion
Forecast Year [2030] USD 25.46 billion
CAGR (%) 11.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Soft Tissue Repair Market

The Soft Tissue Repair Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of soft tissue injuries with aging and obese population
    • Increasing number of orthopedic surgeries
    • Increasing funding from government and other private organization
  • Market Restraints
    • High costs of surgical procedures
  • Market Opportunities
    • Development of technologically advanced products in tissue regeneration
    • Extensive research of tissue regeneration
  • Market Challenges
    • Lack of awareness and limited reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Soft Tissue Repair Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Soft Tissue Repair Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Soft Tissue Repair Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Soft Tissue Repair Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Soft Tissue Repair Market

A detailed market share analysis in the Soft Tissue Repair Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Soft Tissue Repair Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Soft Tissue Repair Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Soft Tissue Repair Market

A strategic analysis of the Soft Tissue Repair Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Soft Tissue Repair Market, highlighting leading vendors and their innovative profiles. These include Acera Surgical Inc., Allergan, PLC, Arthrex, Inc., Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cerner Corporation, CONMED Corporation, CryoLife, Inc., GE Healthcare Inc., Institut Straumann AG, Integra Lifesciences Corporation, Johnson & Johnson, Lifenet Health, Inc., Medline Industries, Inc., Medtronic PLC, Organogenesis Holdings Inc., Pfizer Inc, Smith & Nephew PLC, Stryker Corporation, and Zimmer Biomet Holdings Inc.

Market Segmentation & Coverage

This research report categorizes the Soft Tissue Repair Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Fixation Product, Laparoscopic Instruments, and Mesh Patch. The Fixation Product is further studied across Interference Screw and Suture Anchors. The Mesh Patch is further studied across Biological Mesh and Synthetic Mesh. The Biological Mesh is further studied across Allograft and Xenograft.
  • Based on Application, market is studied across Dental & Breast Reconstruction Repair, Hernia Repair, Orthopedic, Skin Repair, and Vaginal Sling Repair. The Orthopedic is further studied across Dural Repair & Lendon Reinforcement and Sports Medication.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of soft tissue injuries with aging and obese population
      • 5.1.1.2. Increasing number of orthopedic surgeries
      • 5.1.1.3. Increasing funding from government and other private organization
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of surgical procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of technologically advanced products in tissue regeneration
      • 5.1.3.2. Extensive research of tissue regeneration
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and limited reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Soft Tissue Repair Market, by Product

  • 6.1. Introduction
  • 6.2. Fixation Product
    • 6.2.1. Interference Screw
    • 6.2.2. Suture Anchors
  • 6.3. Laparoscopic Instruments
  • 6.4. Mesh Patch
    • 6.4.1. Biological Mesh
      • 6.4.1.1. Allograft
      • 6.4.1.2. Xenograft
    • 6.4.2. Synthetic Mesh

7. Soft Tissue Repair Market, by Application

  • 7.1. Introduction
  • 7.2. Dental & Breast Reconstruction Repair
  • 7.3. Hernia Repair
  • 7.4. Orthopedic
    • 7.4.1. Dural Repair & Lendon Reinforcement
    • 7.4.2. Sports Medication
  • 7.5. Skin Repair
  • 7.6. Vaginal Sling Repair

8. Americas Soft Tissue Repair Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Soft Tissue Repair Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Soft Tissue Repair Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acera Surgical Inc.
  • 2. Allergan, PLC
  • 3. Arthrex, Inc.
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson and Company
  • 6. Boston Scientific Corporation
  • 7. Cerner Corporation
  • 8. CONMED Corporation
  • 9. CryoLife, Inc.
  • 10. GE Healthcare Inc.
  • 11. Institut Straumann AG
  • 12. Integra Lifesciences Corporation
  • 13. Johnson & Johnson
  • 14. Lifenet Health, Inc.
  • 15. Medline Industries, Inc.
  • 16. Medtronic PLC
  • 17. Organogenesis Holdings Inc.
  • 18. Pfizer Inc
  • 19. Smith & Nephew PLC
  • 20. Stryker Corporation
  • 21. Zimmer Biomet Holdings Inc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦